Share this on:
 E-mail
98
VIEWS
 
RECOMMENDS
0
SHARES
About this iReport
  • Not vetted for CNN

  • Click to view Mitch123's profile
    Posted January 5, 2010 by
    Location
    Palatine, Illinois
    Assignment
    Assignment
    This iReport is part of an assignment:
    iReport for CNN

    More from Mitch123

    CryoPort and FedEx its good to be COLD

     

    CryoPort Systems, Inc.

     

    Since reading about this company I realy think they could be something big in the frozen shipping industry. There containers can ship up to 10 days at -150 degress C.

     

    In there recent S1 with the SEC they are working to be listed on the Nasdaq under symbol COLD. I think that symbol is realy neat. Currently listed as CYRX.OB on the OTC market.

     

    Types of Containers: In photos

     

    1.) PSX1000
    Durable soft shell case for non-infectious and non-diagnostic materials.

    2.) AR1000
    Durable hard shell case for non-infectious and non-diagnostic materials..

    3.) DS650
    Durable hard shell case for diagnostic materials, IATA 650 certified.

    4.) DG1000
    Durable hard shell case for infectious materials, IATA 602 certified.

    5.) PS1000
    Personal soft shell case for non-infectious and non-diagnostic materials, not recommended for transport via commercial carriers without additional protective packaging.

    6.) WM1000(CryoPorter Plus)
    Wide mouth unit for non-infectious and non-diagnostic high volume and/or bulky materials.

     

    Facts about the company.

     

    Cryogenic Technology


    CRYOPORT has initiated technological breakthroughs in the field of cryogenic frozen packaging at -150OC, or lower, for the transport of temperature sensitive biological materials with its current reusable shippers now in full production. Three patents for the design of the insulated vacuum vessel have been issued in both domestic and selected overseas countries. In addition, CRYOPORT has completed the development of a unique one-way shipper system, “Cryoport Express”. Cryoport Express has the potential to revolutionize the way the pharmaceutical and biotechnology industries deliver drugs to market and handle specimens in clinical trials, due to its highly efficient design, proprietary technology, ease of use and significant user cost savings. Innovations associated with Cryoport Express will also offer additional intellectual property filings for the Company. No company, other than CRYOPORT, is known to have developed products designed to solve the problems of shipping high value drugs at low temperatures.

     


    The Current Cold Temperature Shipping Market


    Until the recent development of CRYOPORT’S proprietary Cryoport Express shipping system, the pharmaceutical and biotechnology markets had been, and essentially still are, served both inadequately and inefficiently with “dry ice” packaging equipment. The current use of dry ice as a shipping & preserving medium results in: • Low temperature loss after 48 hours and requires “re-icing” for longer shipping times or delays • Risk of specimen deterioration The loss of specimen viability costs these industries hundreds of millions of dollars per year due to: • A delayed time to market for drugs in clinical trials • An increase in the number of patients per trial The number and volume of biological materials shipped in the cold chain is increasing rapidly. According to the Biotechnology Industry Organization (BIO), growth in temperature sensitive products will outpace the rest of the industry with average growth estimated at 15% per year.

     

    CryoPort's Mission Statement

     

    CryoPort’s mission is to provide the most cost effective packaging system that ensures conservation of temperature sensitive biological materials that are critical to the expanding biopharmaceutical and biotechnology industries.


    CryoPort is dedicated to producing superior, affordable cryogenic shipping systems that maintains the integrity of scientific research advanced by the growing biopharma and biotech industries.

     

    CryoPort understands the value of such research and is committed to evolving cryogenic shipping as a new industry standard globally for temperature sensitive materials; such as life-sustaining vaccines and other medical research that are used in clinical trials around the world.

     

    SEC Documents for Cryoport:
    http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001124524&owner=exclude&count=40

     

    Pinksheet.com Quote:
    http://www.pinksheets.com/pink/quote/quote.jsp?symbol=cyrx#getQuote

     

    Yahoo Message Board:
    http://messages.finance.yahoo.com/mb/CYRX.OB

     

    Google Message Board:
    http://finance.google.com/group/google.finance.1869207/topics?hl=en

    Stock Technical Analysis StockTA.com:

    http://www.stockta.com/cgi-bin/analysis.pl?symb=CYRX&num1=1&cobrand=&mode=stock

    What do you think of this story?

    Select one of the options below. Your feedback will help tell CNN producers what to do with this iReport. If you'd like, you can explain your choice in the comments below.
    Be and editor! Choose an option below:
      Awesome! Put this on TV! Almost! Needs work. This submission violates iReport's community guidelines.

    Comments

    Log in to comment

    iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.

    Add your Story Add your Story